Power-Trialysis Slim-Cath catheterRecalls & reported problems across all models
Bard Access Systems, Inc. · 11 models in the FDA device registry
Data updated Oct 18, 2026 from official FDA records · Editorial policy
2 open recalls name at least one Power-Trialysis Slim-Cath catheter model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 6
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls
- 2
We found 11 models of Power-Trialysis Slim-Cath catheter by Bard Access Systems, Inc. in the FDA's device registry (GUDID). Together they are named in 6 adverse event reports in the FDA's MAUDE database, received between Jul 1, 2016 and Feb 12, 2025 — classified as 1 death, 5 malfunctions.
The most frequently reported specific device problem is “Defective Component” (3 reports).
2 FDA recall records name at least one of these models by its device identifier, 2 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
Reports received per month, all models
Power-Trialysis Slim-Cath catheter recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Aug 10, 2026Class IOpen, Classified
this is a downstream recall of class I recall RES 98777
Z-2984-2026 · Root cause: Material/Component Contamination · names 10 of these models · Recall details · FDA record ↗
- May 21, 2026Class IIOpen, Classified
Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Z-2661-2026 · Root cause: Nonconforming Material/Component · names 5 of these models · Recall details · FDA record ↗
Most reported Power-Trialysis Slim-Cath catheter problems
Device problems
- Defective Component3
- Fluid/Blood Leak1
- Insufficient Device Problem Information1
- Material Frayed1
- Material Twisted/Bent1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Burning Sensation1
- Death1
- Erythema1
- Low Blood Pressure/ Hypotension1
- No Consequences Or Impact To Patient1
- Sepsis1
- Skin Inflammation/ Irritation1
Power-Trialysis Slim-Cath catheter models
11 models, most reported first. Each model has its own page with its reports, recalls and device details.
- Power-Trialysis Slim-Cath catheter 5855240CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED2 recalls4 reports
- Power-Trialysis Slim-Cath catheter 5855300CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED2 recalls0 reports
- Power-Trialysis Slim-Cath catheter 5865120CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED2 recalls0 reports
- Power-Trialysis Slim-Cath catheter 5865200CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED2 recalls0 reports
- Power-Trialysis Slim-Cath catheter 5865240CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED2 recalls0 reports
- Power-Trialysis Slim-Cath catheter 5865150CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED1 recall1 death1 report
- Power-Trialysis Slim-Cath catheter 5855200GCATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED1 recall0 reports
- Power-Trialysis Slim-Cath catheter 5865150GCATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED1 recall0 reports
- Power-Trialysis Slim-Cath catheter 5855200CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED1 recall0 reports
- Power-Trialysis Slim-Cath catheter 5855150CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED1 recall0 reports
- Power-Trialysis Slim-Cath catheter 5863150CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED1 report
Recent Power-Trialysis Slim-Cath catheter adverse event reports
The 6 most recent reports across all models, in the reporter's own words as published by the FDA.
MalfunctionFeb 12, 2025Fluid/Blood Leak; Fluid/Blood Leak
IT WAS REPORTED (B)(6) 2024 - INSERTION SITE RED, SLIGHT CLEAR DISCHARGE. (B)(6) 2024 - LEAKED CHEMO DRUG, NO SWELLING, REDNESS. SMALL HOLE AT 4 CM MARK. AFTER LINE REMOVAL ANOTHER FRACTURED AT 7 CM MARK NOTED CANNULA WAS REINSERTED FOR CHEMO. NO OTHER INFORMATION WAS PROVIDED.
Patient problems: Burning Sensation; Erythema; Skin Inflammation/ Irritation
MAUDE report 21363682 ↗MalfunctionSep 6, 2024Defective Component; Defective Component
IT WAS REPORTED BY THE CUSTOMER THAT PURPLE LUMEN CLAMP BROKEN. NO PATIENT IMPACT OR INJURY REPORTED. NO OTHER INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20161990 ↗MalfunctionAug 23, 2024Defective Component; Defective Component
IT WAS REPORTED ON 7/09/2024, WE HAD A TRIPLE LUMEN BARD CENTRAL LINE-PURPLE LUMEN CLAMP BROKEN BARD LOT # REHS3822 PLACED ON (B)(6) 2023. THE DEFECTIVE BARD CATHETER IS STILL ON THE PATIENT, HE IS NOT DONE WITH TREATMENT. THE BROKEN CLAMP WAS A SAFETY ISSUE ONLY AND HAS NOT INTERRUPTED THE PATIENT'S TREATMENT. WE HAVE ATTACHED A REPLACEMENT CLAMP. NO OTHER INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20053754 ↗MalfunctionJun 29, 2022Material Frayed; Defective Component; Material Frayed; Defective Component
IT WAS REPORTED "DURING PLACEMENT OF CVC, IT WAS FOUND THAT THE J WIRE WAS PARTIALLY UNRAVELED AT ABOUT 5CM FROM THE J. NO METAL WAS EVER IN CONTACT WITH THE J WIRE. POTENTIAL EQUIPMENT MALFUNCTION VERSUS SHEARING OF THE J WIRE AT THE TIP OF THE MICROINTRODUCER CATHETER." PATIENT HARM: THE PATIENT SUFFERED EMOTIONAL DISTRESS OR INCONVENIENCE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14860536 ↗MalfunctionMar 19, 2020Material Twisted/Bent; Material Twisted/Bent
IT WAS REPORTED GUIDEWIRE UNABLE TO BE REMOVED WITHOUT EXTREME MEASURES. PLACED IN RIJ FOR VASCULAR ACCESS AND REMOVED AT TIME OF DISCHARGE. NO OTHER INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9857877 ↗DeathJul 1, 2016Insufficient Device Problem Information
AS REPORTED VIA MS&S: SALES REPRESENTATIVE HAD NURSE CONFERENCE CALL WITH MS&S. THE NURSE STATED THAT THEY HAD A FEMALE PATIENT WITH KNOWN SEPSIS WHO HAD A POWER TRIALYSIS PLACED ON (B)(6) 2016. THE NURSE STATED THAT THE PATIENT'S CHEST AND NECK VEINS WERE EXHAUSTED AND THE RIGHT GROIN HAD AN INFECTION. THE POWER TRIALYSIS WAS PLACED INTO THE LEFT FEMORAL VEIN BUT WAS ONLY 15CM IN LENGTH. THE NURSE STATED THAT THE VENOUS PURPLE LUMEN WAS BEING USED FOR VASOPRESSORS LEVOPHED AND DOPAMINE DURING CCRT. THE NURSE REPORTED THAT THE PATIENT'S BLOOD PRESSURE WAS LOW AND THEN WOULD ELEVATE. NURSE STATED THAT THE PATIENT DETERIORATED. THE FAMILY STOPPED TREATMENT AND THE PATIENT EXPIRED. THE NURSE ASKED IF IT IS PERMITTED TO GIVE VASOPRESSORS THROUGH THE DIALYSIS CATHETER PURPLE LUMEN VENOUS LUMEN. THE NURSE STATED THAT THE CATHETER WAS NOT SAVED. MS&S INFORMED THE NURSE THAT IT IS NOT CONTRAINDICATED TO GIVE VASOPRESSORS THROUGH THE VENOUS PURPLE LUMEN OF THE CATHETER.
Patient problems: Death; Low Blood Pressure/ Hypotension; Sepsis; Unspecified Infection
MAUDE report 5764946 ↗
Other Bard Access Systems, Inc. products
- Port Access Needle122 models · 3,744 reports · 3 recalls
- Groshong NXT ClearVue Catheter8 models · 3,266 reports
- PowerPort ClearVUE27 models · 1,993 reports · 15 recalls
- Site~Rite 8 Ultrasound System11 models · 1,965 reports
- PowerPort M.R.I., ChronoFlex22 models · 1,642 reports · 1 recall
- PowerPICC Provena116 models · 1,337 reports · 2 recalls
- PowerPort M.R.I., Groshong10 models · 1,285 reports
- Navarre15 models · 1,228 reports
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page